15/12/2019 · Notícias Zynerba Pharmaceuticals e cotação ZYNE. Cotações em tempo-real grátis, negócios e chat. Zynerba Pharmaceuticals ZYNE preço da ação, gráfico, book, notícias; O fórum mais popular do Brasil. Rankings, ferramentas, índices e muito mais. De Graça! 19/11/2019 · Zynerba Pharmaceuticals chart and ZYNE price. Free real-time prices, trades and chat. Zynerba Pharmaceuticals ZYNE preço da ação, gráfico, book, notícias; O fórum mais popular do Brasil. Rankings, ferramentas, índices e muito mais. De Graça! 19/11/2019 06:55:32 Produtos ADVFN Fale Conosco Cadastro Gratis Login. 24/10/2019 · ZYNE Cotação da empresa Zynerba Pharmaceuticals com preços de ações, gráfico, forum, dividendos e balanços na bolsa de valores da NASDAQ Zynerba Pharmaceuticals ZYNE preço da ação, gráfico, book, notícias; O fórum mais popular do Brasil. 12/08/2019 · Dados de preços históricos Zynerba Pharmaceuticals e gráficos ZYNE. Cotações em tempo-real grátis, negócios e chat. Zynerba Pharmaceuticals ZYNE preço da ação, gráfico, book, notícias; O fórum mais popular do Brasil. Rankings, ferramentas, índices e muito mais. De Graça!
Read current news for ZYNE. ZYNERBA PHARMACEUTICALS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District for Eastern District of Pennsylvania against Zynerba Pharmaceuticals, Inc. What's going on at Zynerba Pharmaceuticals NASDAQ:ZYNE? View breaking news headlines for ZYNE stock from trusted media outlets at MarketBeat. ZYNE Zynerba Pharmaceuticals, Inc. Common Stock. Data is currently not available. DATA AS OF Dec 19, 2019. $6.26 0.40 6.83%. ZYNE Zynerba Pharmaceuticals, Inc. Common Stock ZYNE News Headlines. Zynerba Pharmaceuticals, Inc. Common Stock ZYNE News Headlines. Oct 23, 2019. 7 Stocks to Buy With 100% Upside Potential.
Visualize o gráfico ZYNERBA PHARMACEUTICALS INC ao vivo para acompanhar o movimento do preço de suas ações. Encontre previsões de mercado, ZYNE finanças e notícias do mercado. 29/01/2019 · Investors have likely already noticed that Zynerba Pharmaceuticals NASDAQ:ZYNE stock is soaring today. This doesn’t have to do with any Zynerba Pharmaceuticals news announcement from the company. Rather, it has to do with options for its CEO. Zynerba Pharmaceuticals. View the real-time ZYNE price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Zynerba Pharmaceuticals against related stocks people have also bought like APHA, HEXO, ACB, and CRON. 21,458 people own Zynerba.
Find a variety of Zynerba Pharmaceuticals Inc statistics including live ZYNE stock quotes, market price charts, market cap, and everything you need to know to invest in ZYNE. 25/12/2019 · Do Hedge Funds Love Zynerba Pharmaceuticals Inc ZYNE? We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Get breaking news and analysis on Zynerba Pharmaceuticals, Inc. ZYNE stock, price quote and chart, trading and investing tools.
06/12/2019 · This means that Zynerba Pharmaceuticals is performing better than its sector in terms of year-to-date returns. Breaking things down more, ZYNE is a member of the Medical - Generic Drugs industry, which includes 26 individual companies and currently sits at 140 in the Zacks Industry Rank. 06/11/2019 · Find the latest Zynerba Pharmaceuticals, Inc. ZYNE stock quote, history, news and other vital information to help you with your stock trading and investing.
05/11/2019 · Zynerba Pharma Announces Positive Top Line Data From Believe 1 Open Label Phase 2 Study Of Zygel In Developmental And Epileptic Encephalopathies Sept 18 Reuters - Zynerba Pharmaceuticals Inc
Zynerba Pharmaceuticals ZYNE Dips More Than Broader Markets: What You Should Know. by Zacks Equity Research Published on June 26,2019. Zynerba Pharmaceuticals ZYNE closed at $12.48 in the latest trading session, marking a -0.56% move from the prior day. ZYNE. Find real-time ZYNE - Zynerba Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. View detailed financial information, real-time news, videos, quotes and analysis on Zynerba Pharmaceuticals Inc. NASDAQ:ZYNE. Explore commentary on Zynerba Pharmaceuticals Inc. and hear what the experts at TheStreet are saying about ZYNE. 19/12/2019 · Pawar Law Group announces that a class action lawsuit on behalf of shareholders who purchased shares of Zynerba Pharmaceuticals, Inc. ZYNE from March 11, 2019 through September 17, 2019, inclusive the “Class Period”. The lawsuit seeks to recover damages for Zynerba Pharmaceuticals, Inc. investors under the federal securities laws.
24/11/2019 · ZYNE Gráfico da empresa Zynerba Pharmaceuticals com preços de ações, gráfico, forum, dividendos e balanços na bolsa de valores da NASDAQ Zynerba Pharmaceuticals ZYNE preço da ação, gráfico, book, notícias; O fórum mais popular do Brasil. Real-time trade and investing ideas on Zynerba Pharmaceuticals ZYNE from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. ZYNE Stock Summary. Zynerba Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 7.15% of US listed stocks. With a price/sales ratio of 2,006.9, Zynerba Pharmaceuticals Inc has a higher such ratio than 99.84% of stocks in our set.
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. 07/11/2019 · Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It engages in the development and commercialization of transdermal pharmaceutically-produced cannabinoid treatments for rare and near-rare neurological and psychiatric, or neuropsychiatric, disorders in patients with high unmet medical needs. Stock analysis for Zynerba Pharmaceuticals Inc ZYNE:NASDAQ GM including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Every investor in Zynerba Pharmaceuticals, Inc. NASDAQ:ZYNE should be aware of the most powerful shareholder groups. Institutions often own shares in more established companies, while it’s not unusual to see insiders own a fair bit of smaller companies.
Comida De Festa Temática Jamaicana 2021
Aparafusadora Compacta Sem Fio 2021
21st Topper For Cake 2021
Exercícios De Ginástica Para Estômago Liso 2021
Sopa De Ervilha Habitante Imitadora 2021
100k Bloxburg House 2021
Produtos Do Espinheiro Marítimo 2021
Filmes Mais Votados Em 2019 2021
Oração Pela Alma Da Minha Avó 2021
Torneira Pia Da Cozinha 2021
Super Chef Game 2021
Horário Do Buffet Chet E Matt 2021
Meepo Dota 2 2021
Placa De Controle Do Fogão A Gás Frigidaire 2021
Engenharia Mecatrônica 2021
Mapa De Escolas Na Minha Área 2021
Golmaal Again Filme Tudo Mp3 Músicas Baixar 2021
Suporte Para Bard Build S8 2021
Vestido Longo Com Camisa De Leopardo 2021
Parede Anterior Mi Leads 2021
Tornozelo Cinta Cabo Máquina Exercícios 2021
Half Marathon Finder 2019 2021
Nike Air Max 3.26 Vermelho 2021
Citações Primeiro Amor Nunca Pode Ser Esquecido 2021
Esboço De Lápis De Mão 2021
Conjunto De Brocas Ridgid 2021
Beautiful In Polish 2021
Kamikaze Álbum Completo Online 2021
Gibson Girl Painting 2021
Bolsas De Estudo Na Universidade Do Sul De Charleston 2021
Mini-carregadeira Cat 299d Para Venda 2021
Small Bag Supreme 2021
Índia Vs Índias Ocidentais 2018 Destaques Hotstar 2021
Titular Do Cartão Ysl Loulou 2021
Treinador De Futebol De Hugh Freeze 2021
Bram Stoker 1897 2021
Projetos Do Banheiro Com Cabines De Chuveiro 2021
Conjuntos De Móveis De Quarto De Segunda Mão 2021
20000 Jardas Em Milhas 2021
Como Se Tornar Infértil 2021